Standard UK Delivery from £2.49

Please enable cookies to use this site. Why?


Cephorum is an antibiotic tablet with a variety of uses but mainly gastrointestinal, orogential, respiratory and skin infections.

It is available in 2 sizes: Cephorum 250mg Tablet and Cephorum 500mg Tablet

Cephorum 500mg Tablet for Dogs

Cephorum 500mg Tablet for Dogs


Cephorum 500mg Tablets are indicated for the treatment of urinary tract infections and bacterial skin infections caused by Klebsiella pneumoniae. Each tablet contains Cefalexin Monohydrate...[More info]

Cephorum 250mg Tablet for Dogs

Cephorum 250mg Tablet for Dogs


Cephorum 250mg Tablets are indicated for the treatment of bacterial skin infections and urinary tract infections caused by Klebsiella pneumoniae. Each tablet contains Cefalexin 250mg...[More info]


Contra-indications, warnings, etc
Use of Cephorum® Tablets should be based on susceptibility testing and take in to account official and local antimicrobial policies.
Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to cefalexin and may decrease the effectiveness of treatment with penicillins, due to potential cross-resistance.
In case of an allergic reaction, treatment should be withdrawn.
Cephorum® Tablets should not be administered to animals which are known to be hypersensitive to cefalexin.
As with other antibiotics which are excreted mainly by the kidneys, accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced, antimicrobials known to be nephrotoxic should not be administered concurrently and the product should be used only according to a risk/benefit assessment by the responsible veterinarian.
Vomiting and/or diarrhoea have been observed in dogs. In rare cases hypersensitivity can occur. In cases of hypersensitivity reactions the treatment should be stopped.
The safety of the veterinary medicinal product has not been established in bitches during pregnancy and lactation. Use only accordingly to the benefit/risk assessment by the responsible veterinarian.
The bactericidal activity of cephalosporins is reduced by concomitant administration of bacteriostatic acting compounds (macrolides, sulphonamides and tetracyclines). Nephrotoxicity can be increased when 1st generation cephalosporins are combined with polypeptide antibiotics, aminoglycosides and some diuretics (furosemide). Concomitant use with such active substances should be avoided.
Symptoms of overdose include nausea, vomiting, epigastric distress, diarrhoea and haematuria. Treatment should be symptomatic.
Keep out of reach of children. For animal treatment only.

Special precautions to be taken by the person administering the tablets to animals:
Cephalosporins may cause sensitisation (allergy) following injection,inhalation, ingestion or skin contact. Sensitivity to penicillin may lead to cross-sensitivity to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious.
1. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.
2. Handle this product with great care to avoid exposure, taking all recommended precautions.
3. If you develop symptoms following exposure such as a skin rash you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention.
Wash hands after use.
Summary of Products Characteristics is available on request from Forum Animal Health.